The Cost-effectiveness of the Olweus Bullying Prevention Program: Results from a Modelling Study
Overview
Authors
Affiliations
Exposure to bullying affects around 3-5 percent of adolescents in secondary school and is related to various mental health problems. Many different anti-bullying programmes are currently available, but economic evaluations are lacking. The aim of this study is to identify the cost effectiveness of the Olweus Bullying Prevention Program (OBPP). We constructed a decision-tree model for a Swedish secondary school, using a public payer perspective, and retrieved data on costs and effects from the published literature. Probabilistic sensitivity analysis to reflect the uncertainty in the model was conducted. The base-case analysis showed that using the OBPP to reduce the number of victims of bullying costs 131,250 Swedish kronor (€14,470) per victim spared. Compared to a relevant threshold of the societal value of bullying reduction, this indicates that the programme is cost-effective. Using a relevant willingness-to-pay threshold shows that the OBPP is a cost-effective intervention.
The cost-effectiveness of school-based interventions for chronic diseases: a systematic review.
Lin G, Werner K, Alqunaiebet A, Hamza M, Alkanhal N, Alsukait R Cost Eff Resour Alloc. 2024; 22(1):26.
PMID: 38605333 PMC: 11008027. DOI: 10.1186/s12962-024-00511-w.
Modelling in economic evaluation of mental health prevention: current status and quality of studies.
Ha N, Huong N, Anh V, Quynh Anh N BMC Health Serv Res. 2022; 22(1):906.
PMID: 35831821 PMC: 9281039. DOI: 10.1186/s12913-022-08206-9.
Diaz-Caneja C, Martin-Babarro J, Abregu-Crespo R, Huete-Diego M, Gimenez-Dasi M, Serrano-Marugan I Front Pediatr. 2021; 9:628984.
PMID: 33981651 PMC: 8107271. DOI: 10.3389/fped.2021.628984.
Le L, Esturas A, Mihalopoulos C, Chiotelis O, Bucholc J, Chatterton M PLoS Med. 2021; 18(5):e1003606.
PMID: 33974641 PMC: 8148329. DOI: 10.1371/journal.pmed.1003606.
Systematic Review of Violence Prevention Economic Evaluations, 2000-2019.
Peterson C, Kearns M Am J Prev Med. 2021; 60(4):552-562.
PMID: 33608188 PMC: 7987799. DOI: 10.1016/j.amepre.2020.11.002.